Neogenesis vs. apoptosis As main components of pancreatic beta cell ass changes in glucose-infused normal and mildly diabetic adult rats.
We have investigated in adult rats made mildly diabetic by a low dose of streptozotocin (35 mg/kg; STZ rats) and in nondiabetic rats (ND rats) the mechanisms leading to adaptive changes in the beta cell mass, during glucose infusion and several days after stopping infusion. As early as 24 h of glucose infusion, the beta cell mass was maximally increased in ND and STZ rats. In both groups, this increase was due mainly to a rapid activation of neogenesis of new endocrine cells rather than to an increase in beta cell proliferation. Seven days after stopping glucose infusion, the beta cell mass returned to basal values in both groups as a result of stimulation of beta cell apoptosis and a decrease in beta cell replication rate. In glucose-infused ND rats, changes in the beta cell mass were correlated to insulin secretion, whereas in STZ rats, insulin secretion in response to glucose was still impaired whatever the beta cell mass. In conclusion, the data stress the impressive plasticity of the endocrine pancreas of adult rats. They also show that changes in beta cell mass in ND and STZ rats resulted from a disruption in the balance between neogenesis and apoptosis.
Bernard
C
C
Laboratoire de Physiopathologie de la Nutrition, CNRS ESA 7059, Université Paris 7, Paris-France. cbernard@paris7.jussieu.fr
Berthault
M F
MF
Saulnier
C
C
Ktorza
A
A
D000818:Animals; D017209:Apoptosis; D002455:Cell Division; D003921:Diabetes Mellitus, Experimental / Q000378:metabolism / Q000473:pathology*; D005947:Glucose / Q000008:administration & dosage*; D007150:Immunohistochemistry; D007328:Insulin / Q000378:metabolism; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000378:metabolism / Q000473:pathology*; D008297:Male; D009929:Organ Size; D051381:Rats; D017208:Rats, Wistar; D013311:Streptozocin
D007328:Insulin; D013311:Streptozocin; D005947:Glucose